Aclaris Therapeutics

ACRS · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Total Revenue

$1.78M

Previous year: $2.77M

-35.8%

EPS

-$0.13

Previous year: -$0.15

-13.3%

R&D expenses

$11.4M

Previous year: $8.76M

+30.7%

G&A expenses

$5.39M

Previous year: $4.75M

+13.3%

Licensing expenses

$1.34M

Previous year: $1.29M

Loading...

Aclaris Therapeutics

Unlock previous datapoints

Upgrade

Aclaris Therapeutics

Unlock previous datapoints

Upgrade

Aclaris Therapeutics Revenue by Segment

Revenue by Segment

Contract research Revenue

CapyFin.com

Licensing Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$452M

P/E Ratio

-3.02

Sector

N/A

Industry

N/A

52-Week High

$4.5

52-Week Low

$1.05

R&D expenses

$11.4M

G&A expenses

$5.39M

Licensing expenses

$1.34M

Revaluation of contingent consideration

$1.5M

Interest income

$2.02M

Products

Get in Touch

Resources

Aclaris Therapeutics

Aclaris Therapeutics

Aclaris Therapeutics

Aclaris Therapeutics Revenue by Segment

Revenue by Segment

Contract research Revenue

Licensing Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics